CHRU de Strasbourg-Hopital de Hautepierre

Strasbourg 67200

0 studies enrolling now · 4 studies all time

What they study most

Alzheimer Disease, Crohn's Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Sjogrens Syndrome

Studies at this site

• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• Nipocalimab in Moderate to Severe Sjogren's Disease — Running, not enrolling
• A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma — Stopped early
• Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) — Running, not enrolling